Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.

Autor: Velayutham NK; Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Chennai, Tamil Nadu, India., Thamaraikani T; Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Chennai, Tamil Nadu, India., Wahab S; Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia., Khalid M; Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia., Ramachawolran G; Department of Foundation, RCSI and UCD Malaysia Campus, George Town, Pulau Pinang, Malaysia., Abullais SS; Department of Periodontics and Community Dental Sciences, College of Dentistry, King Khalid University, Abha, Saudi Arabia., Wong LS; Faculty of Health and Life Sciences, INTI International University, Nilai, Malaysia., Sekar M; School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang Jaya, Selangor, Malaysia.; Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Science, Chennai, India., Gan SH; School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang Jaya, Selangor, Malaysia., Ebenezer AJ; Trichy Research Institute of Biotechnology Pvt Ltd, Trichy, Tamil Nadu, India., Ravikumar M; Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Chennai, Tamil Nadu, India., Subramaniyan V; Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Subang Jaya, Selangor, Malaysia., Mat Rani NNI; Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh, Perak, Malaysia., Wu YS; Department of Biological Sciences and Centre for Virus and Vaccine Research, School of Medical and Life Sciences, Sunway University, Subang Jaya, Selangor, Malaysia., Jeyabalan S; Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (DU), Chennai, Tamil Nadu, India.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2023 Mar 28; Vol. 14, pp. 1150270. Date of Electronic Publication: 2023 Mar 28 (Print Publication: 2023).

H4R activation utilizes distinct signaling pathways for the production of RANTES and IL-13 in human mast cells.

Autor: Ebenezer AJ; a Department of Biotechnology , School of Bioengineering, SRM University , Kattankulathur , Tamil Nadu , India., Arunachalam P; b Department of Pediatrics , SRM Medical College Hospital and Research Centre , Kattankulathur , Tamil Nadu , India., Elden BT; a Department of Biotechnology , School of Bioengineering, SRM University , Kattankulathur , Tamil Nadu , India.

Publikováno v: Journal of receptor and signal transduction research [J Recept Signal Transduct Res] 2017 Apr; Vol. 37 (2), pp. 133-140. Date of Electronic Publication: 2016 Jul 12.

Erratum: Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.

Publikováno v: Frontiers in Pharmacology; 2024, p1-1, 1p

Erratum: Stylopine: a potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.

Publikováno v: Frontiers in Pharmacology; 2023, p01-01, 1p

Resveratrol protects against asthma-induced airway inflammation and remodeling by inhibiting the HMGB1/TLR4/NF-κB pathway.

Autor: Jiang, Huanhuan¹ (AUTHOR), Duan, Junyan¹ (AUTHOR), Xu, Kaihong¹ (AUTHOR), Zhang, Wenbo¹ (AUTHOR) rpsf14@163.com

Publikováno v: Experimental & Therapeutic Medicine. Jul2019, Vol. 18 Issue 1, p459-466. 8p.